| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 14.24▼ | 14.27▼ | 14.20▼ | 14.06▲ | 14.48▼ |
| MA10 | 14.25▼ | 14.23▼ | 14.24▼ | 14.24▲ | 16.07▼ |
| MA20 | 14.23▼ | 14.27▼ | 14.21▼ | 14.33▼ | 17.84▼ |
| MA50 | 14.30▼ | 14.13▲ | 14.15▲ | 16.12▼ | 19.30▼ |
| MA100 | 14.17▲ | 14.29▼ | 14.42▼ | 17.90▼ | 18.85▼ |
| MA200 | 14.11▲ | 14.53▼ | 15.55▼ | 19.02▼ | 14.68▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.005▲ | -0.011▼ | 0.000▼ | 0.085▲ | -0.423▼ |
| RSI | 46.817▼ | 48.776▼ | 49.885▼ | 38.375▼ | 33.900▼ |
| STOCH | 45.862 | 56.421 | 33.663 | 23.176 | 15.523▼ |
| WILL %R | -65.574 | -65.574 | -67.692 | -56.629 | -91.068▼ |
| CCI | -3.495 | -30.603 | -42.232 | -33.721 | -116.434▼ |
|
Wednesday, August 05, 2026 05:30 AM
Favorable, differentiated safety profile and durable single-agent clinical activity, including in heavily pretreated subjects with lung cancer remaining on treatment for over a year Oral weekly ...
|
|
Monday, May 04, 2026 04:53 AM
Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transactions may contain terms that could limit superior competing offers.
|
|
Wednesday, December 17, 2025 06:34 AM
WATERTOWN, Mass., Dec. 17, 2025 (GLOBE NEWSWIRE) -- Acrivon Therapeutics, Inc. ("Acrivon" or "Acrivon Therapeutics") (Nasdaq: ACRV), a clinical stage biotechnology company discovering and developing ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 04/09/26 | 14.03 | 14.50 | 14.00 | 14.28 | 44,151 |
| 03/09/26 | 14.08 | 14.47 | 14.08 | 14.14 | 17,972 |
| 02/09/26 | 14.05 | 14.474 | 13.70 | 14.04 | 48,768 |
| 01/09/26 | 13.88 | 14.11 | 13.68 | 13.93 | 30,681 |
| 31/08/26 | 13.97 | 14.09 | 13.8401 | 13.93 | 19,051 |
| 28/08/26 | 14.06 | 14.26 | 13.915 | 13.96 | 28,364 |
| 27/08/26 | 14.36 | 14.38 | 14.07 | 14.10 | 37,012 |
| 26/08/26 | 14.76 | 14.77 | 14.27 | 14.28 | 32,033 |
| 25/08/26 | 14.985 | 14.985 | 14.85 | 14.86 | 11,350 |
| 24/08/26 | 14.92 | 14.975 | 14.83 | 14.83 | 9,241 |
|
|
||||
|
|
||||
|
|